Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
Clinical trial NCT02175121 · COMPLETED
Trial details
- NCT number
- NCT02175121
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-03-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.